Treatment-resistant major depressive disorder remains inadequately treated with currently available antidepressants. Opioid receptors (ORs) are involved in the pathophysiology of depression yet remain ...

Sedative-, hypnotic-, or anxiolytic- (SHA-) related disorders include SHA intoxication, SHA withdrawal, and SHA-use disorder. These disorders result from abuse of a class of medications known as ...

Objective: The primary aim of this study was to evaluate the psychomotor effects of mexazolam versus placebo in patients with generalised anxiety disorder (GAD). Patients and methods: This was a ...

Disulfiram is a drug used to treat chronic alcoholism. However, studies suggest that it also inhibits chemokine receptor signaling pathways that are associated with the regulation of anxiety in ...

Xabi Martinez-Mendia, a researcher at the EHU-University of the Basque Country, has analyzed how adolescent psychotropic drug consumption is linked to gender inequality and economic factors in 32 ...

A 67-year-old patient currently being treated for anxiety secondary to narcotic withdrawal was started on three anti-anxiety medications that were subsequently tapered to diazepam only. Because the ...

U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a study published online Aug. 19 in JAMA Network Open ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...

Sedative-, hypnotic-, or anxiolytic- (SHA-) related disorders include SHA intoxication, SHA withdrawal, and SHA-use disorder. These disorders result from abuse of a class of medications known as ...